DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response

BACKGROUND: As a leading cause of respiratory disease, influenza A virus (IAV) infection remains a pandemic threat in annual seasonal outbreaks. Given the limitation of existing anti-influenza therapeutic drugs, development of new drugs is urgently required. Flavonoids extracted from Artemisia rupes...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Ming, Wang, Huiqiang, Ma, Linlin, Yan, Haiyan, Wu, Shuo, Gu, Zhengyi, Li, Yuhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381609/
https://www.ncbi.nlm.nih.gov/pubmed/30786886
http://dx.doi.org/10.1186/s12985-019-1125-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381609/
https://www.ncbi.nlm.nih.gov/pubmed/30786886
http://dx.doi.org/10.1186/s12985-019-1125-9

Ejemplares similares